BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21519012)

  • 1. Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria.
    van der Ploeg AP; van Akkooi AC; Rutkowski P; Nowecki ZI; Michej W; Mitra A; Newton-Bishop JA; Cook M; van der Ploeg IM; Nieweg OE; van den Hout MF; van Leeuwen PA; Voit CA; Cataldo F; Testori A; Robert C; Hoekstra HJ; Verhoef C; Spatz A; Eggermont AM
    J Clin Oncol; 2011 Jun; 29(16):2206-14. PubMed ID: 21519012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EORTC Melanoma Group sentinel node protocol identifies high rate of submicrometastases according to Rotterdam Criteria.
    van der Ploeg AP; van Akkooi AC; Schmitz PI; Koljenovic S; Verhoef C; Eggermont AM
    Eur J Cancer; 2010 Sep; 46(13):2414-21. PubMed ID: 20621467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes.
    van Akkooi AC; Nowecki ZI; Voit C; Schäfer-Hesterberg G; Michej W; de Wilt JH; Rutkowski P; Verhoef C; Eggermont AM
    Ann Surg; 2008 Dec; 248(6):949-55. PubMed ID: 19092339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma.
    Lee JH; Essner R; Torisu-Itakura H; Wanek L; Wang H; Morton DL
    J Clin Oncol; 2004 Sep; 22(18):3677-84. PubMed ID: 15365064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pigmentation in the sentinel node correlates with increased sentinel node tumor burden in melanoma patients.
    van Lanschot CG; Koljenović S; Grunhagen DJ; Verhoef C; van Akkooi AC
    Melanoma Res; 2014 Jun; 24(3):261-6. PubMed ID: 24608184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The predictive power of serum S-100B for non-sentinel node positivity in melanoma patients.
    Damude S; Hoekstra HJ; Bastiaannet E; Muller Kobold AC; Kruijff S; Wevers KP
    Eur J Surg Oncol; 2016 Apr; 42(4):545-51. PubMed ID: 26831006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma.
    Scheri RP; Essner R; Turner RR; Ye X; Morton DL
    Ann Surg Oncol; 2007 Oct; 14(10):2861-6. PubMed ID: 17882497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel node tumor burden in prediction of prognosis in melanoma patients.
    Palve J; Ylitalo L; Luukkaala T; Jernman J; Korhonen N
    Clin Exp Metastasis; 2020 Apr; 37(2):365-376. PubMed ID: 32076905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Completion lymph node dissection after a positive sentinel node: no longer a must?
    van der Ploeg AP; van Akkooi AC; Verhoef C; Eggermont AM
    Curr Opin Oncol; 2013 Mar; 25(2):152-9. PubMed ID: 23328628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel node biopsy in melanoma: Current controversies addressed.
    Madu MF; Wouters MW; van Akkooi AC
    Eur J Surg Oncol; 2017 Mar; 43(3):517-533. PubMed ID: 27590685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sentinel lymph node spread determines quantitatively melanoma seeding to non-sentinel lymph nodes and survival.
    Ulmer A; Dietz K; Werner-Klein M; Häfner HM; Schulz C; Renner P; Weber F; Breuninger H; Röcken M; Garbe C; Fierlbeck G; Klein CA
    Eur J Cancer; 2018 Mar; 91():1-10. PubMed ID: 29316475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is complete lymph node dissection after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary? A meta-analysis.
    Nagaraja V; Eslick GD
    Eur J Surg Oncol; 2013 Jul; 39(7):669-80. PubMed ID: 23571104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma.
    van Akkooi AC; de Wilt JH; Verhoef C; Graveland WJ; van Geel AN; Kliffen M; Eggermont AM
    Eur J Cancer; 2006 Feb; 42(3):372-80. PubMed ID: 16403622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing the prognostic role of melanoma sentinel lymph nodes through microscopic tumour burden characterization: clinical usefulness in patients who do not undergo complete lymph node dissection.
    Borgognoni L; Bellucci F; Urso C; Manneschi G; Gerlini G; Brandani P; Chiarugi C; Gelli R; Giannotti V; Sestini S
    Melanoma Res; 2019 Apr; 29(2):163-171. PubMed ID: 30778017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimarker reverse transcriptase-polymerase chain reaction assay in lymphatic drainage and sentinel node tumor burden.
    Rutkowski P; Nowecki ZI; van Akkooi AC; Kulik J; Wanda M; Siedlecki JA; Eggermont AM; Ruka W
    Ann Surg Oncol; 2010 Dec; 17(12):3314-23. PubMed ID: 20607422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis in patients with sentinel node-positive melanoma without immediate completion lymph node dissection.
    van der Ploeg AP; van Akkooi AC; Rutkowski P; Cook M; Nieweg OE; Rossi CR; Testori A; Suciu S; Verhoef C; Eggermont AM;
    Br J Surg; 2012 Oct; 99(10):1396-405. PubMed ID: 22961519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of completion lymphadenectomy after positive sentinel node biopsy in patients with melanoma.
    Oude Ophuis CM; van Akkooi AC; Rutkowski P; Powell WE; Robert C; Testori A; van Leeuwen BL; Siegel P; Eggermont AM; Verhoef C; Grünhagen DJ
    Br J Surg; 2017 May; 104(6):726-733. PubMed ID: 28218385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of a new scoring system for predicting non-sentinel node positivity in sentinel node-positive melanoma patients.
    Wevers KP; Murali R; Bastiaannet E; Scolyer RA; Suurmeijer AJ; Thompson JF; Hoekstra HJ
    Eur J Surg Oncol; 2013 Feb; 39(2):179-84. PubMed ID: 23137997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Completion Lymph Node Dissection Based on Risk of Nonsentinel Metastasis in Cutaneous Melanoma of the Head and Neck.
    Fritsch VA; Cunningham JE; Lentsch EJ
    Otolaryngol Head Neck Surg; 2016 Jan; 154(1):94-103. PubMed ID: 26399717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases.
    Zdzienicki M; Rutkowski P; Nowecki ZI; van Akkooi AC; Michej W; Dziewirski W; Świtaj T; Pieńkowski A; Sałamacha M; Bylina E; Eggermont AM
    Eur J Surg Oncol; 2013 Mar; 39(3):304-10. PubMed ID: 23298828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.